Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.
Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, Koizumi F, Tamura T, Saito D, Shimoda T, Saka M, Fukagawa T, Katai H, Sano T, Sasako M, Nishio K. Yamada Y, et al. Among authors: kato k. Cancer Sci. 2008 Nov;99(11):2193-9. doi: 10.1111/j.1349-7006.2008.00935.x. Epub 2008 Jan 11. Cancer Sci. 2008. PMID: 18957060 Free article. Clinical Trial.
Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer.
Yamada Y, Arao T, Matsumoto K, Gupta V, Tan W, Fedynyshyn J, Nakajima TE, Shimada Y, Hamaguchi T, Kato K, Taniguchi H, Saito Y, Matsuda T, Moriya Y, Akasu T, Fujita S, Yamamoto S, Nishio K. Yamada Y, et al. Among authors: kato k. Cancer Sci. 2010 Aug;101(8):1886-90. doi: 10.1111/j.1349-7006.2010.01595.x. Epub 2010 Apr 21. Cancer Sci. 2010. PMID: 20491774 Free article.
Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy.
Makuuchi Y, Honda K, Osaka Y, Kato K, Kojima T, Daiko H, Igaki H, Ito Y, Hoshino S, Tachibana S, Watanabe T, Furuta K, Sekine S, Umaki T, Watabe Y, Miura N, Ono M, Tsuchida A, Yamada T. Makuuchi Y, et al. Among authors: kato k. Cancer Sci. 2013 Aug;104(8):1045-51. doi: 10.1111/cas.12187. Epub 2013 Jun 13. Cancer Sci. 2013. PMID: 23648090 Free PMC article.
Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
Hironaka S, Tsubosa Y, Mizusawa J, Kii T, Kato K, Tsushima T, Chin K, Tomori A, Okuno T, Taniki T, Ura T, Matsushita H, Kojima T, Doki Y, Kusaba H, Fujitani K, Taira K, Seki S, Nakamura T, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Hironaka S, et al. Among authors: kato k. Cancer Sci. 2014 Sep;105(9):1189-95. doi: 10.1111/cas.12486. Cancer Sci. 2014. PMID: 25041052 Free PMC article. Clinical Trial.
[Multidisciplinary therapy for esophagogastric junction cancer].
Sudo K, Honma Y, Kato K. Sudo K, et al. Among authors: kato k. Nihon Shokakibyo Gakkai Zasshi. 2015 Oct;112(10):1791-9. doi: 10.11405/nisshoshi.112.1791. Nihon Shokakibyo Gakkai Zasshi. 2015. PMID: 26440682 Japanese. No abstract available.
Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
Tsushima T, Mizusawa J, Sudo K, Honma Y, Kato K, Igaki H, Tsubosa Y, Shinoda M, Nakamura K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group of Japan Clinical Oncology Group (JCOG). Tsushima T, et al. Among authors: kato k. Medicine (Baltimore). 2016 May;95(20):e3699. doi: 10.1097/MD.0000000000003699. Medicine (Baltimore). 2016. PMID: 27196482 Free PMC article. Clinical Trial.
9,692 results